Our findings offer valuable insights into the role of LOC344887 in modulating the SHP-1/STAT3/HMGA2 signaling pathway, positioning it as a key regulator and a promising therapeutic target in the metastatic progression of HCC. This evidence concerns the gene STAT3 and hepatocellular carcinoma.